News - June 18, 2020

Need for a Mutual Recognition Agreement between the EU and UK

EUCOPE, together with other European pharmaceutical trade associations, wrote a letter to the presidents of the Commission, Council and Parliament, as well as Trade Commissioner Phil Hogan and the EU’s chief negotiator Michel Barnier, voicing our shared concern about the… read more

News - June 16, 2020

Consultation on EU Pharmaceutical Strategy

The European Commission just opened the public consultation on its proposed pharmaceutical strategy for the EU. In the Commission’s words, the strategy intends to ‘address the current issues of access, availability and affordability of medicines, while still promoting sustainable innovation… read more

News - June 2, 2020

EUCOPE Response Statement – Pharmaceutical Strategy Roadmap

EUCOPE examined with great interest the European Commission’s Pharmaceutical Strategy Roadmap. We welcome the European Commission’s acknowledgement of the crucial role played by the pharmaceutical sector in the economy of the EU, as well as the creation of a future-proof,… read more

News - May 15, 2020

A 20th Anniversary Analysis of the EU OMP Regulation

The 10th European Conference on Rare Diseases (ECRD), the largest patient-led event on rare diseases and orphan products, presented an excellent opportunity for exchange among the patient community and experts from various backgrounds. The conference allowed EUCOPE to share the… read more